Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

113.00p
   
  • Change Today:
    -0.50p
  • 52 Week High: 150.00
  • 52 Week Low: 108.00
  • Currency: UK Pounds
  • Shares Issued: 84.81m
  • Volume: 97,125
  • Market Cap: £95.83m
  • RiskGrade: 196
  • Beta: 0.00

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
73.59% above the market average73.59% above the market average73.59% above the market average73.59% above the market average73.59% above the market average
52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average52.94% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
11.89% above the market average11.89% above the market average11.89% above the market average11.89% above the market average11.89% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Price Book Ratio
50.99% below the market average50.99% below the market average50.99% below the market average50.99% below the market average50.99% below the market average
18.75% below the sector average18.75% below the sector average18.75% below the sector average18.75% below the sector average18.75% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
91.72% below the market average91.72% below the market average91.72% below the market average91.72% below the market average91.72% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average
Price Chg 3m
66.34% below the market average66.34% below the market average66.34% below the market average66.34% below the market average66.34% below the market average
27.78% below the sector average27.78% below the sector average27.78% below the sector average27.78% below the sector average27.78% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
77.39% below the market average77.39% below the market average77.39% below the market average77.39% below the market average77.39% below the market average
87.88% below the sector average87.88% below the sector average87.88% below the sector average87.88% below the sector average87.88% below the sector average
Momentum 20
86.87% below the market average86.87% below the market average86.87% below the market average86.87% below the market average86.87% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
52.78% below the market average52.78% below the market average52.78% below the market average52.78% below the market average52.78% below the market average
3.03% below the sector average3.03% below the sector average3.03% below the sector average3.03% below the sector average3.03% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
67.91% below the market average67.91% below the market average67.91% below the market average67.91% below the market average67.91% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
11.78% below the market average11.78% below the market average11.78% below the market average11.78% below the market average11.78% below the market average
21.21% above the sector average21.21% above the sector average21.21% above the sector average21.21% above the sector average21.21% above the sector average
Operating Profit Loss
61.09% below the market average61.09% below the market average61.09% below the market average61.09% below the market average61.09% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
2.41% above the market average2.41% above the market average2.41% above the market average2.41% above the market average2.41% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Cash
14.87% above the market average14.87% above the market average14.87% above the market average14.87% above the market average14.87% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
16.91% above the market average16.91% above the market average16.91% above the market average16.91% above the market average16.91% above the market average
17.65% above the sector average17.65% above the sector average17.65% above the sector average17.65% above the sector average17.65% above the sector average
Buys 1y
70.31% below the market average70.31% below the market average70.31% below the market average70.31% below the market average70.31% below the market average
39.13% below the sector average39.13% below the sector average39.13% below the sector average39.13% below the sector average39.13% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 113.00p
Change Today -0.50p
% Change -0.44 %
52 Week High 150.00
52 Week Low 108.00
Volume 97,125
Shares Issued 84.81m
Market Cap £95.83m
Beta 0.00
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.19% below the market average29.19% below the market average29.19% below the market average29.19% below the market average29.19% below the market average
45.45% below the sector average45.45% below the sector average45.45% below the sector average45.45% below the sector average45.45% below the sector average
Price Trend
5.01% below the market average5.01% below the market average5.01% below the market average5.01% below the market average5.01% below the market average
22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average
Income Not Available
Growth
43.19% above the market average43.19% above the market average43.19% above the market average43.19% above the market average43.19% above the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average

Diaceutics Dividends

No dividends found

Trades for 25-Jun-2025

Time Volume / Share Price
16:51 48,530 @ 112.50p
14:35 1,817 @ 112.55p
14:00 20,000 @ 113.00p
14:00 7,298 @ 113.00p
14:00 2,702 @ 113.00p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page